[Bleomycin-induced pneumonia].
We report on a case of a 38-year old patient with fatal bleomycin-induced pneumonitis. Clinical presentation, the impact of risk factors, therapeutic means and perioperative considerations to prevent this rare but life-threatening complication are reviewed.
Berger
K
K
Abteilung für Anästhesiologie und Intensivemedizin, Bundeswehrkrankenhaus Hamburg.
Göpfert
A
A
Berkel
H
H
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects*; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D003131:Combined Modality Therapy; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000628:therapy; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin; D005047:Etoposide; D002945:Cisplatin
Bleomycin-induzierte Pneumonitis.